[Towards bioproduction of anticancer drugs by yeast]

Med Sci (Paris). 2019 May;35(5):417-419. doi: 10.1051/medsci/2019087. Epub 2019 May 22.

[Article in French]

Authors

Vincent Courdavault¹, Nicolas Papon², Marc Clastre¹

Affiliations

¹ Université de Tours, EA2106 Biomolécules et biotechnologies végétales, 31, avenue Monge, 37200 Tours, France.
² Groupe d'étude des interactions hôte-pathogène, GEIHP, EA 3142, SFR ICAT 4208, Université d'Angers, Université de Brest, Institut de biologie en santé, IRIS, CHU d'Angers, 4, rue Larrey, 49100 Angers, France.

PMID: 31115322
DOI: 10.1051/medsci/2019087

No abstract available

Publication types

News

MeSH terms

Antineoplastic Agents / economics
Antineoplastic Agents / metabolism*
Antineoplastic Agents, Phytogenic / isolation & purification
Drug Discovery / economics
Drug Discovery / methods
Drug Discovery / trends
Drug Industry / economics
Drug Industry / standards
Drug Industry / trends
Humans
Metabolic Engineering / methods
Metabolic Engineering / trends*
Neoplasms / drug therapy
Saccharomyces cerevisiae / metabolism*
Synthetic Biology / economics
Synthetic Biology / methods
Synthetic Biology / trends
Vinblastine / analogs & derivatives
Vinblastine / biosynthesis
Vinblastine / isolation & purification
Vinblastine / therapeutic use
Vinca Alkaloids / biosynthesis
Vinca Alkaloids / isolation & purification
Vinca Alkaloids / therapeutic use

Substances

Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Vinca Alkaloids
vindoline
Vinblastine
catharanthine